Dudediligence.

CNS Pharmaceuticals, Inc

CNSPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$5.6MSep ’24−$3.2MDec ’24−$4.3MMar ’25−$2.4MJun ’25−$3.2MSep ’25$9.9MDec ’25−$4.9MMar ’26−$2.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$14.5M−$15.3M−$18.9M−$14.9M−$16.0M
Net income−$14.5M−$15.3M−$18.9M−$14.9M−$15,987
Operating cash flow−$13.5M−$10.6M−$14.1M−$17.1M−$13.8M
Free cash flow−$13.5M−$10.6M−$14.1M−$17.1M−$13.8M
Cash$5.0M$10.1M$548,721$6.5M$7.2M
Shares outstanding949.1K1.6M2.5K117.8K632.5K